State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

If you've been considering Ozempic but are concerned about the cost, MyStart offers a convenient alternative at a fraction of ...

Shares of several companies including Suzlon, IndiGo, State Bank of India, and M&M, among others, will be in the news today ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

The fast-moving, big business of weight-loss drugs is already shifting to its next stage ... It's an unsettling realization ...

Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine-skeptic Robert F. Kennedy Jr. to the nation's ...

The study, which was published in the Journal of Sports Science & Medicine in 2021, had nine healthy people use the treadmill ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.